This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Dec 17;126(25):2656-7.

doi: 10.1182/blood-2015-10-676890.

Idelalisib has CLL on the run!

Jennifer R Brown¹

Affiliations

PMID: 26679541
DOI: 10.1182/blood-2015-10-676890

Free article

Comment

Idelalisib has CLL on the run!

Jennifer R Brown. Blood. 2015.

Free article

. 2015 Dec 17;126(25):2656-7.

doi: 10.1182/blood-2015-10-676890.

Author

Jennifer R Brown¹

Affiliation

¹ DANA-FARBER CANCER INSTITUTE.

PMID: 26679541
DOI: 10.1182/blood-2015-10-676890

No abstract available

PubMed Disclaimer

Comment on

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.
O'Brien SM, Lamanna N, Kipps TJ, Flinn I, Zelenetz AD, Burger JA, Keating M, Mitra S, Holes L, Yu AS, Johnson DM, Miller LL, Kim Y, Dansey RD, Dubowy RL, Coutre SE. O'Brien SM, et al. Blood. 2015 Dec 17;126(25):2686-94. doi: 10.1182/blood-2015-03-630947. Epub 2015 Oct 15. Blood. 2015. PMID: 26472751 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems